MDxHealth SA Price to Book Ratio 2018-2025 | MDXH
Historical price to book ratio values for MDxHealth SA (MDXH) over the last 10 years. The current price to book ratio for MDxHealth SA as of January 13, 2026 is 0.00.
| MDxHealth SA Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2026-01-13 | 3.61 | 0.00 | |
| 2025-09-30 | 4.65 | 0.00 | |
| 2025-03-31 | 1.42 | 0.00 | |
| 2024-12-31 | 2.37 | 0.00 | |
| 2024-09-30 | 2.08 | 0.00 | |
| 2024-06-30 | 2.39 | $-0.32 | -7.40 |
| 2024-03-31 | 2.59 | 0.00 | |
| 2023-12-31 | 3.94 | $0.26 | 14.92 |
| 2023-09-30 | 2.80 | $0.66 | 4.24 |
| 2023-06-30 | 3.41 | 0.00 | |
| 2023-03-31 | 3.24 | $1.39 | 2.33 |
| 2022-12-31 | 6.61 | 0.00 | |
| 2022-09-30 | 6.75 | 0.00 | |
| 2022-06-30 | 8.35 | 0.00 | |
| 2022-03-31 | 8.30 | 0.00 | |
| 2021-12-31 | 9.52 | 0.00 | |
| 2021-06-30 | 0.00 | 0.00 | |
| 2020-12-31 | 0.00 | 0.00 | |
| 2020-06-30 | 0.00 | 0.00 | |
| 2019-12-31 | 0.00 | 0.00 | |
| 2019-06-30 | 0.00 | 0.00 | |
| 2018-12-31 | 0.00 | 0.00 | |
| 2017-12-31 | 0.00 | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.162B | $0.090B |
| MDxHealth SA is a healthcare company which provides actionable molecular diagnostic information for diagnosis and treatment of cancer. The company's tests are based on proprietary gene methylation and other molecular technologies and assist physicians with the diagnosis of cancer. MDxHealth SA is headquartered in Herstal, Belgium. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.335B | 44.34 |
| Tempus AI (TEM) | United States | $12.322B | 0.00 |
| Doximity (DOCS) | United States | $8.258B | 34.00 |
| Hims & Hers Health (HIMS) | United States | $7.362B | 59.89 |
| IRhythm Technologies (IRTC) | United States | $5.445B | 0.00 |
| Hinge Health (HNGE) | United States | $3.816B | 0.00 |
| Privia Health (PRVA) | United States | $2.881B | 180.15 |
| Inspire Medical Systems (INSP) | United States | $2.816B | 46.60 |
| Heartflow (HTFL) | United States | $2.707B | 0.00 |
| 10x Genomics (TXG) | United States | $2.506B | 0.00 |
| Omnicell (OMCL) | United States | $2.297B | 46.96 |
| Azenta (AZTA) | United States | $1.726B | 70.83 |
| Enovis (ENOV) | United States | $1.541B | 8.09 |
| Schrodinger (SDGR) | United States | $1.373B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.364B | 0.00 |
| Butterfly Network (BFLY) | United States | $1.079B | 0.00 |
| Phreesia (PHR) | United States | $1.033B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.870B | 0.00 |
| Talkspace (TALK) | United States | $0.661B | 133.00 |
| Standard BioTools (LAB) | United States | $0.581B | 0.00 |
| Claritev (CTEV) | United States | $0.528B | 0.00 |
| Evolent Health (EVH) | United States | $0.463B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.387B | 0.00 |
| Carlsmed (CARL) | United States | $0.384B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.348B | 0.00 |
| TruBridge (TBRG) | United States | $0.328B | 15.06 |
| Senseonics Holdings (SENS) | United States | $0.291B | 0.00 |
| CapsoVision (CV) | United States | $0.281B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.273B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.204B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.174B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.173B | 0.00 |
| CareCloud (CCLD) | United States | $0.125B | 6.84 |
| Outset Medical (OM) | United States | $0.101B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.092B | 0.00 |
| HeartBeam (BEAT) | United States | $0.088B | 0.00 |
| Pulmonx (LUNG) | United States | $0.082B | 0.00 |
| American Well (AMWL) | United States | $0.081B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.068B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.067B | 0.00 |
| Precipio (PRPO) | United States | $0.046B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.043B | 0.00 |
| 111 (YI) | China | $0.032B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.022B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.021B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Zhongchao (ZCMD) | China | $0.014B | 0.00 |
| HeartSciences (HSCS) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |